Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized anesthesia medication guidance in obese patients using body composition analysis
ChiCTR2200056598Phase 4Not yet recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and esketamine in obesity (9 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Incidence of respiratory depression. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
remimazolamalfentanilesketamine
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2200056598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056598.